Compounds > ciprofloxacin

ciprofloxacin and tamsulosin

ciprofloxacin has been researched along with tamsulosin in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (54.55)	29.6817
2010's	5 (45.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Alexander, RB; Kusek, JW; Landis, JR; Litwin, MS; Nickel, JC; Nyberg, LM; Propert, KJ; Schaeffer, AJ	1
Alexander, RB; Comiter, CV; Datta, NS; Fowler, JE; Knauss, JS; Kusek, JW; Landis, JR; Litwin, MS; McNaughton-Collins, M; Nadler, RB; Nickel, JC; Nyberg, LM; O'Leary, MP; Pontari, MA; Propert, KJ; Schaeffer, AJ; Shoskes, DA; Wang, Y; Zeitlin, SI	1
Weidner, W	1
Atkin, MS; Biri, H; Deniz, N; Kiraç, M	1

Reviews

1 review(s) available for ciprofloxacin and tamsulosin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

3 trial(s) available for ciprofloxacin and tamsulosin

Article	Year
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology, 2002, Volume: 59, Issue:6 Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Multicenter Studies as Topic; Pelvic Pain; Prostatitis; Randomized Controlled Trials as Topic; Research Design; Sulfonamides; Tamsulosin	2002
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Annals of internal medicine, 2004, Oct-19, Volume: 141, Issue:8 Topics: Adrenergic alpha-Antagonists; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Pelvic Pain; Placebos; Prostatitis; Sulfonamides; Syndrome; Tamsulosin; Treatment Failure	2004
Ureteroscopy: the first-line treatment for distally located ureteral stones smaller than 10 mm. Urology journal, 2014, 01-04, Volume: 10, Issue:4 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Female; Fluid Therapy; Humans; Male; Parasympatholytics; Prospective Studies; Sulfonamides; Tamsulosin; Time Factors; Treatment Outcome; Ureteral Calculi; Ureteroscopy; Urological Agents; Watchful Waiting; Young Adult	2014

Other Studies

7 other study(ies) available for ciprofloxacin and tamsulosin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Summaries for patients. Treating men with chronic prostatitis/chronic pelvic pain syndrome. Annals of internal medicine, 2004, Oct-19, Volume: 141, Issue:8 Topics: Adrenergic alpha-Antagonists; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Pelvic Pain; Placebos; Prostatitis; Sulfonamides; Syndrome; Tamsulosin; Treatment Failure	2004
Treating chronic prostatitis: antibiotics no, alpha-blockers maybe. Annals of internal medicine, 2004, Oct-19, Volume: 141, Issue:8 Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Humans; Male; Pelvic Pain; Prostatitis; Sulfonamides; Tamsulosin; Treatment Failure	2004